Search

everythinglearnresearchcommunity

for

Search:↓

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Six existing drugs may help block virus entry in COVID-19.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

Niosomes are effective carriers for targeted drug delivery, improving drug stability and efficiency.

Niosomes are a promising, stable, and cost-effective drug delivery system with potential for improved targeting and safety.

Clindamycin-loaded nanoparticles effectively treat MRSA-infected wounds and promote healing.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

The new treatment effectively heals drug-resistant bacteria-infected wounds.

P-SLN nanoparticles effectively deliver podophyllotoxin to the skin.

Nanocarriers can make acne treatments more effective and gentle on the skin.

Lidocaine-loaded microparticles effectively relieve pain and fight bacteria in wounds.

Ultrasound can improve targeted drug delivery, making treatments more effective with fewer side effects.

[6]-Gingerdiol 3-monoacetate shows promise for treating T. whipplei infections.

Injection lipolysis effectively reduces small fat deposits and should be done with care and proper patient selection.

The document concludes that H2-antagonists and proton pump inhibitors are highly effective for ulcers, eradicating Helicobacter pylori is important to prevent recurrence, and misoprostol helps with NSAID-related ulcers.

Nanotechnology can effectively deliver antimicrobial peptides for treating infections.

The new gel effectively treats MRSA-infected wounds for longer.

The traditional herbal formulas Yongdamsagan-Tang and Paljung-san, along with the drug finasteride, can reduce inflammation and may work together without affecting each other's effectiveness against benign prostatic hyperplasia.

The new drug delivery systems made with surfactants and block polymers are stable and not toxic.

Two existing drugs may help treat COVID-19 by inhibiting a key viral protein.

New drugs and combination therapies are improving treatment for lower urinary tract symptoms.

The new drug carriers show promise for better targeting and treating ovarian cancer.

Molybdenum oxide nanozymes can effectively treat and monitor acute kidney injury by reducing oxidative stress.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

Wedelolactone selectively kills prostate cancer cells without harming normal cells.

The new gel improves treatment of tough skin infections.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.